A novel prognostic signature based on immunogenic cell death score predicts outcomes and response to transcatheter arterial chemoembolization and immunotherapy in hepatocellular carcinoma.
Journal of cancer research and clinical oncology（2023）
摘要
The ICDSsig can potentially predict outcomes and therapeutic responses for patients with liver cancer and may assist clinicians in designing individualized treatment strategies.
更多查看译文
关键词
Hepatocellular carcinoma, Immunogenic cell death (ICD), Tumor immune microenvironment (TIME), Prognosis, Transcatheter arterial chemoembolization (TACE)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要